Dublin, May 02, 2022 (GLOBE NEWSWIRE) — The report “Myopia and Presbyopia Treatment Market Share, Size, Trends, Industry Analysis Report, by Type of Myopia Treatment, by Type treatment of presbyopia; by region; segment forecast, 2022-2030” has been added to from ResearchAndMarkets.com offer.
According to a new study, the global myopia and presbyopia treatment market size is expected to reach USD 30.66 billion by 2030. The report provides a detailed overview of current market dynamics and provides growth analysis market future.
The rising incidence of visual impairment coupled with the growing number of geriatric populations are the major factors likely to propel the demand for the industry across the globe. The increasing prevalence of visual impairment problems, along with the growing risks of pathological conditions associated with retinal damage, glaucoma, and cataracts are expected to drive the growth of the global industry.
Based on the type of myopia treatment, the corrective segment is dominating the global industry and is expected to lead the industry during the forecast period. Factors such as increasing prevalence of myopia in developing countries are contributing to the growth of the segment. The large pool of patients is attributed to the growing demand for corrective lenses among the population.
The growing geriatric population worldwide is expected to drive the growth of the industry. The geriatric population is more prone to vision loss, as most adults develop lifestyle-related vision disorders. For example, according to the United Nations, there will be 727 million people aged 65 or over worldwide in 2021. Additionally, the number of older people is expected to double to 1.5 billion by 2050.
Thus, this increasing incidence is a determining factor for the demand of the industry. Moreover, the growing number of ongoing researches and growing product pipeline globally are expected to boost the growth of the industry.
Market players such as ALCON Inc., AbbVie, Alcon Vision LLC, Bausch & Lomb Incorporated, The Cooper Companies Inc., Carl Zeiss AG, Essilor Ltd., Bausch Health Companies Inc., Hagg Striet UK, Johnson & Johnson Vision, Orasis Pharmaceuticals, Nidek Corporation, Regeneron Pharmaceuticals Inc., Sydnexis, Topcon Corporation, and Zimmer Ophthalmic Systems AG are some of the key players operating in the global market.
Various vendors in the market are introducing their innovations in the global market to strengthen their geographic footprint. For example, in October 2021, Allergan received FDA (Food & Drug Administration) approval for Vuity (pilocarpine hydrochloric acid ophthalmic solution) 1.25%, used for the treatment of presbyopia.
Main topics covered:
2. Executive Summary
3. Research methodology
4. Global Myopia and Presbyopia Treatment Market Overview
4.1. Myopia and Presbyopia Treatment Market – Industry Overview
4.2. Myopia and Presbyopia Treatment Market Dynamics
4.2.1. Drivers and opportunities
220.127.116.11. Increased prevalence of eye disorders
18.104.22.168. Technological innovations
4.2.2. Constraints and challenges
22.214.171.124. Data security
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining power of suppliers (moderate)
4.3.2. Threats from new entrants: (low)
4.3.3. Bargaining power of buyers (moderate)
4.3.4. Substitute Threat (Moderate)
4.3.5. Rivalry between existing companies (high)
4.4. PESTLE analysis
4.5. Myopia and Presbyopia Treatment Industry Trends
4.6. Value chain analysis
4.7. COVID-19 Impact Analysis
5. Global Myopia and Presbyopia Treatment Market, By Type of Myopia Treatment
6. Global Myopia and Presbyopia Treatment Market, By Type of Presbyopia Treatment
7. Global Myopia and Presbyopia Treatment Market, By Geography
8. Competitive landscape
8.1. Expansion and acquisition analysis
9. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/97z0cq
Global myopia and presbyopia treatment market
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900